Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
5p15.33
15%
95% Confidence Interval
13%
Adenocarcinoma
8%
African American
13%
Anti-cyclic Citrullinated Peptide (anti-CCP)
8%
Autoimmune Disease
12%
Biological Pathways
10%
BRCA2
13%
Cancer Risk
13%
Checkpoint Kinase 2 (CHEK2)
10%
Colorectal Cancer
9%
Combined Analysis
9%
Cutaneous Melanoma
24%
Disease Detection
9%
Disease-associated
10%
European Ancestry
11%
Fine Mapping
9%
Genetic Architecture
13%
Genetic Overlap
10%
Genetic Risk
10%
Genetic Susceptibility
9%
Genetic Variants
21%
Genome-wide Association
9%
Genome-wide Association Study
89%
Genotype
13%
Histology-specific
10%
Human Leukocyte Antigen
10%
Linkage Analysis
10%
Lung Cancer
45%
Lung Cancer Risk
60%
Melanoma
38%
Melanoma Risk
24%
Meta-analysis
27%
Nevus
9%
Next-generation Sequencing
8%
Odds Ratio
22%
Parkinson's Disease
9%
Path Analysis
10%
Primary Biliary Cirrhosis
9%
Rare Variants
10%
Rheumatoid Arthritis
55%
Risk Loci
22%
Risk Variant
9%
Single nucleotide Polymorphism
79%
SNP
21%
Solid Tumors
10%
Squamous Cell Carcinoma (SqCC)
8%
Susceptibility Loci
31%
Systemic Sclerosis
9%
Texas
13%
Biochemistry, Genetics and Molecular Biology
Allele
21%
Association Study
9%
Autoantibody
6%
Autoimmunity
14%
Biological Pathway
6%
Blood Plasma
8%
BRCA2
10%
Candidate Gene
9%
Case-Control Study
12%
CHEK2
11%
CHRNA5
6%
Chromosome
22%
DNA Repair
5%
Epistasis
6%
Gene Linkage
29%
Gene Linkage Disequilibrium
7%
Genetic Architecture
9%
Genetic Determinism
5%
Genetic Divergence
43%
Genetic Overlap
10%
Genetic Risk
6%
Genetic Susceptibility
16%
Genetic Variation
14%
Genetics
21%
Genome Wide Association Study
9%
Genome-Wide Association Study
97%
Genomics
10%
Genotyping
8%
Haplotype
12%
HLA-DRB1
5%
Homozygosity
5%
Human Leukocyte Antigen
14%
Linkage Analysis
10%
Major Histocompatibility Complex
7%
Missense
5%
Myeloid
5%
Next Generation Sequencing
13%
Nicotinic Acetylcholine Receptor
6%
Nucleic Acid
5%
Peptide
6%
Promoter Region
6%
RAD52
6%
Rare Variant
10%
Receptor Gene
5%
Signal Transduction
6%
Single Nucleotide Polymorphism
42%
Single-Nucleotide Polymorphism
100%
Susceptibility Gene
10%
Telomere
5%
Tumor Suppressor Gene
6%
